We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATR icon
12851
AptarGroup
ATR
$8.45B
-3,641
Closed -$428K
ATR icon
12852
PUT
AptarGroup
ATR
$8.45B
-17,100
Closed -$2.09M
ATRC icon
12853
CALL
AtriCure
ATRC
$2.51B
-4,200
Closed -$292K
ATRC icon
12854
AtriCure
ATRC
$2.51B
-4,629
Closed -$322K
AUID icon
12855
authID Inc
AUID
$8.4M
-1,638
Closed -$184K
AUTL
12856
Autolus Therapeutics
AUTL
$628M
-15,670
Closed -$65.9K
AUTL
12857
PUT
Autolus Therapeutics
AUTL
$628M
-22,200
Closed -$115K
AUUDW
12858
DELISTED
Auddia Inc Warrants
AUUDW
-11,548
Closed -$5K
AVDX
12859
CALL
DELISTED
AvidXchange
AVDX
-55,900
Closed -$842K
AVNW icon
12860
Aviat Networks
AVNW
$277M
-46,608
Closed -$1.36M
JBIO
12861
Jade Biosciences
JBIO
$1.35B
-451
Closed -$186K
AVTX icon
12862
CALL
Avalo Therapeutics
AVTX
$1.08B
-25
Closed -$122K
AWAY icon
12863
Amplify Travel Tech ETF
AWAY
$37.9M
-52,519
Closed -$1.28M
AWR icon
12864
PUT
American States Water
AWR
$3.52B
-2,600
Closed -$269K
AWRE icon
12865
PUT
Aware
AWRE
$26.8M
-10,400
Closed -$33K
AXGN icon
12866
Axogen
AXGN
$2.78B
-14,555
Closed -$126K
AXS icon
12867
PUT
AXIS Capital
AXS
$7.23B
-6,600
Closed -$360K
AXTI icon
12868
AXT Inc
AXTI
$4.39B
-17,049
Closed -$128K
AXSM icon
12869
Axsome Therapeutics
AXSM
$10.8B
-116,144
Closed -$3.6M
AYI icon
12870
Acuity Brands
AYI
$10.2B
-3,428
Closed -$659K
AYTU icon
12871
PUT
AYTU BioPharma
AYTU
$24M
-815
Closed -$22K
BAC.PRL icon
12872
Bank of America Series L
BAC.PRL
$3.95B
-913
Closed -$1.32M
BANF icon
12873
CALL
BancFirst
BANF
$3.71B
-3,700
Closed -$261K
BBAG icon
12874
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
$1.05B
-47,167
Closed -$2.54M
BBC icon
12875
Virtus Biotech Clinical Trials ETF
BBC
$52.6M
-9,830
Closed -$379K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.